Aaron E. Carnes

736 total citations
19 papers, 550 citations indexed

About

Aaron E. Carnes is a scholar working on Ecology, Genetics and Infectious Diseases. According to data from OpenAlex, Aaron E. Carnes has authored 19 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ecology, 12 papers in Genetics and 9 papers in Infectious Diseases. Recurrent topics in Aaron E. Carnes's work include Bacteriophages and microbial interactions (12 papers), Viral gastroenteritis research and epidemiology (8 papers) and Virus-based gene therapy research (6 papers). Aaron E. Carnes is often cited by papers focused on Bacteriophages and microbial interactions (12 papers), Viral gastroenteritis research and epidemiology (8 papers) and Virus-based gene therapy research (6 papers). Aaron E. Carnes collaborates with scholars based in United States, Australia and Portugal. Aaron E. Carnes's co-authors include James A. Williams, Clague P. Hodgson, Jeremy Luke, Jim Williams, D.M.F. Prazeres, Kristala L. J. Prather, Gabriel A. Monteiro, Stephen A. Rodriguez, Jared L. Nelson and Ping Sun and has published in prestigious journals such as Biotechnology Advances, Biotechnology and Bioengineering and Vaccine.

In The Last Decade

Aaron E. Carnes

19 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aaron E. Carnes United States	12	349	276	173	141	80	19	550
Jeremy Luke United States	12	242 0.7×	192 0.7×	98 0.6×	127 0.9×	96 1.2×	15	421
Daisuke Imamura Japan	13	371 1.1×	297 1.1×	238 1.4×	77 0.5×	29 0.4×	22	607
Christine Ludwig Germany	10	342 1.0×	114 0.4×	64 0.4×	188 1.3×	98 1.2×	12	577
Ruzhong Jin United States	11	368 1.1×	252 0.9×	97 0.6×	167 1.2×	34 0.4×	11	475
Natalie K. Connors Australia	10	205 0.6×	79 0.3×	154 0.9×	152 1.1×	61 0.8×	20	465
Tiago Vicente Portugal	11	374 1.1×	166 0.6×	59 0.3×	175 1.2×	25 0.3×	16	572
Kathleen Wilke Germany	7	416 1.2×	154 0.6×	138 0.8×	37 0.3×	66 0.8×	8	570
Thomas Klauser Germany	8	319 0.9×	258 0.9×	191 1.1×	61 0.4×	51 0.6×	9	636
Gholamreza Ahmadian Iran	8	305 0.9×	89 0.3×	94 0.5×	241 1.7×	138 1.7×	10	662
Laural B. Harper United States	5	330 0.9×	156 0.6×	47 0.3×	187 1.3×	247 3.1×	5	585

Countries citing papers authored by Aaron E. Carnes

Since Specialization

Citations

This map shows the geographic impact of Aaron E. Carnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron E. Carnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron E. Carnes more than expected).

Fields of papers citing papers by Aaron E. Carnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron E. Carnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron E. Carnes. The network helps show where Aaron E. Carnes may publish in the future.

Co-authorship network of co-authors of Aaron E. Carnes

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron E. Carnes. A scholar is included among the top collaborators of Aaron E. Carnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron E. Carnes. Aaron E. Carnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Hodgson, Clague P., Aaron E. Carnes, & James A. Williams. (2017). Recent advances in non-viral vectors for gene therapy & vaccination. Cell and Gene Therapy Insights. 3(2). 95–101. 1 indexed citations

Tiwari, Neha, et al.. (2016). 712. Challenges of Production of NanoPlasmid with Large Gene insert using the HyperGRO™ Fermentation Process. Molecular Therapy. 24. S281–S281. 2 indexed citations

Prather, Kristala L. J., et al.. (2014). Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: Fermentation strategies and impact on downstream processing. Journal of Biotechnology. 186. 119–127. 18 indexed citations

Carnes, Aaron E. & James A. Williams. (2014). Plasmid Fermentation Process for DNA Immunization Applications. Methods in molecular biology. 1143. 197–217. 5 indexed citations

Luke, Jeremy, Aaron E. Carnes, & James A. Williams. (2014). Development of Antibiotic-Free Selection System for Safer DNA Vaccination. Methods in molecular biology. 1143. 91–111. 12 indexed citations

Lancto, Cheryl A., Linda K. Foster, Brian McComb, et al.. (2014). A Noncytolytic α Toxin Recombinant Protein Protects Turkeys AgainstClostridium septicumChallenge. Avian Diseases. 58(4). 566–571. 8 indexed citations

Nelson, Jared L., et al.. (2013). Antibiotic-free production of a herpes simplex virus 2 DNA vaccine in a high yield cGMP process. Human Vaccines & Immunotherapeutics. 9(10). 2211–2215. 17 indexed citations

Carnes, Aaron E.. (2012). High-Yield Plasmid DNA Production. Genetic Engineering & Biotechnology News. 32(8). 42–43. 1 indexed citations

Carnes, Aaron E., et al.. (2010). Plasmid DNA fermentation strain and process‐specific effects on vector yield, quality, and transgene expression. Biotechnology and Bioengineering. 108(2). 354–363. 34 indexed citations

10.

Luke, Jeremy, Aaron E. Carnes, Clague P. Hodgson, & James A. Williams. (2010). Vector Insert-Targeted Integrative Antisense Expression System for Plasmid Stabilization. Molecular Biotechnology. 47(1). 43–49. 4 indexed citations

11.

Carnes, Aaron E., et al.. (2010). Critical design criteria for minimal antibiotic‐free plasmid vectors necessary to combine robust RNA Pol II and Pol III‐mediated eukaryotic expression with high bacterial production yields. The Journal of Gene Medicine. 12(10). 818–831. 20 indexed citations

12.

Luke, Jeremy, Aaron E. Carnes, Ping Sun, et al.. (2010). Thermostable tag (TST) protein expression system: Engineering thermotolerant recombinant proteins and vaccines. Journal of Biotechnology. 151(3). 242–250. 11 indexed citations

13.

Luke, Jeremy, Aaron E. Carnes, Clague P. Hodgson, & James A. Williams. (2009). Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system. Vaccine. 27(46). 6454–6459. 86 indexed citations

14.

Williams, James A., Aaron E. Carnes, & Clague P. Hodgson. (2009). Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream production. Biotechnology Advances. 27(4). 353–370. 130 indexed citations

15.

Carnes, Aaron E., et al.. (2009). Plasmid DNA production combining antibiotic‐free selection, inducible high yield fermentation, and novel autolytic purification. Biotechnology and Bioengineering. 104(3). 505–515. 16 indexed citations

16.

Williams, James A., et al.. (2009). Generic plasmid DNA production platform incorporating low metabolic burden seed‐stock and fed‐batch fermentation processes. Biotechnology and Bioengineering. 103(6). 1129–1143. 53 indexed citations

17.

Carnes, Aaron E. & Jim Williams. (2007). Plasmid DNA Manufacturing Technology. Recent Patents on Biotechnology. 1(2). 151–166. 38 indexed citations

18.

Carnes, Aaron E., Clague P. Hodgson, & James A. Williams. (2006). Inducible Escherichia coli fermentation for increased plasmid DNA production. Biotechnology and Applied Biochemistry. 45(3). 155–166. 62 indexed citations

19.

Carnes, Aaron E.. (2005). Fermentation Design for the Manufacture of Therapeutic Plasmid DNA. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact